Current and emerging issues in nosocomial infections and antibiotic resistance
dc.contributor.author | Tridgell, Z. | |
dc.date.accessioned | 2019-05-15T09:34:07Z | |
dc.date.available | 2019-05-15T09:34:07Z | |
dc.date.issued | 2011 | |
dc.identifier.citation |
Tridgell, Z. (2011) 'Current and emerging issues in nosocomial infections and antibiotic resistance', The Plymouth Student Scientist, 4(2), p. 252-266. | en_US |
dc.identifier.issn | 1754-2383 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/13959 | |
dc.description.abstract |
Antibiotic resistant pathogens are a major cause of nosocomial infections and exhibit an extraordinary ability to constantly adapt and acquire resistance determinants to overcome the effects of commonly prescribed antimicrobials. Glycopeptide resistant Enterococcus faecium, multidrug resistant Pseudomonas aeruginosa, Clostridium difficile and Escherichia coli are all pathogens of clinical interest, increasing in prevalence and causing large outbreaks of infection within hospitals. On the other hand, the emerging potential of vancomycin resistant Staphylococcus aureus (VRSA) and linezolid resistance in Gram-positive pathogens to follow suite provides a serious concern for the future treatment of hospital-acquired infections. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Plymouth | |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Antibiotic resistance | en_US |
dc.subject | nosocomial infection | en_US |
dc.subject | vancomycin | en_US |
dc.subject | multidrug resistance | en_US |
dc.subject | linezolid | en_US |
dc.title | Current and emerging issues in nosocomial infections and antibiotic resistance | en_US |
dc.type | Article | |
plymouth.journal | The Plymouth Student Scientist |